RLMD
Relmada Therapeutics Inc
3.70$
-1.6%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Cash Flow
Relmada Therapeutics Inc (RLMD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -46 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -16 | -16 | -13 | -6.5 | -6.0 | 0.0 | -28 | -92 | -104 | -52 | -52 | -46 | |
| 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | |
| 2.0 | 0.8 | 1.2 | 0.7 | 0.5 | 0.0 | 21 | 40 | 44 | 44 | 30 | 15 | |
| 5.7 | -12 | 0.0 | 1.2 | 5.0 | 2.8 | 21 | 42 | 38 | – | – | – | |
| -1.1 | -1.1 | 1.7 | -0.2 | 0.7 | 0.0 | 11 | -7.9 | 11 | 3.1 | -1.6 | -3.9 | |
| 0.0 | 0.0 | 0.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.0 | 0.0 | -0.6 | 0.0 | 0.0 | -0.1 | -34 | -54 | 20 | 50 | 52 | -48 | |
| 13 | – | – | – | 18 | 114 | – | – | 43 | – | – | – | |
| -0.3 | -0.3 | -0.3 | 6.5 | -0.3 | -0.4 | -0.1 | 0.0 | -0.1 | – | – | – | |
| 13 | 13 | -0.3 | -0.3 | 6.5 | 0.1 | 28 | 188 | 45 | -0.1 | 0.0 | 94 | |
| -3.1 | -3.1 | -14 | -6.8 | 0.5 | 0.0 | -34 | 42 | -39 | -1.3 | -0.2 | -0.4 | |
| -16 | -16 | -14 | -6.5 | -6.0 | 0.0 | -28 | -92 | -104 | -52 | -52 | -46 |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.